`
The global PFAS testing market size 2026 was valued at USD 377.8 million in 2025 and is projected to grow from USD 439.0 million in 2026 to USD 1,037.4 million by 2034, reflecting a robust CAGR of 11.3% over the forecast period. North America led the global market with a dominant share of 45.26% in 2025.
PFAS testing involves laboratory analysis of samples — including water, blood, soil, and food — to detect and confirm the presence of per- and polyfluoroalkyl substances. Growing regulatory scrutiny, rising public health awareness, and the expansion of environmental monitoring programs are key forces shaping this market.
Key Market Drivers
Public Health Concerns: PFAS chemicals are now widely detected in human populations. According to the International Chemical Secretariat (ICS, 2025), approximately 99% of all humans carry measurable PFAS levels in their bloodstreams. These substances are linked to serious health conditions including thyroid disruption, immune dysfunction, and certain cancers — compelling governments and healthcare institutions to mandate routine PFAS monitoring.
Regulatory Pressure: Escalating regulatory scrutiny across the U.S. and Europe is directly fueling demand. Stricter drinking water standards, food safety limits, and contact material regulations are pushing industries to increase the frequency and scope of PFAS testing.
Corporate and Legal Accountability: Growing litigation, corporate liability concerns, and remediation project requirements are also motivating organizations to invest in PFAS testing infrastructure.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pfas-testing-market-115213
Market Restraints & Challenges
High Equipment Costs: Advanced PFAS testing requires specialized instruments such as liquid chromatography–tandem mass spectrometry (LC-MS/MS) and gas chromatography mass spectrometry (GC-MS). According to Axion Analytical (2025), new gas chromatographs range from USD 30,000 to USD 100,000 — a significant barrier, particularly in emerging economies like Brazil and Mexico.
Lack of Standardization: Regulatory bodies have established validated methods only for a limited set of PFAS compounds (e.g., EPA Methods 533, 537.1, 1633). The absence of universal protocols across regions creates inconsistency in results and complicates regulatory compliance for industries worldwide.
Segmentation Highlights
By Type: The products segment — encompassing instruments (LC-MS, GC-MS, NMR) and consumables — held the largest share in 2025, driven by rising diagnostic volumes and continuous product innovation. The software & services segment is expected to grow at a CAGR of 11.6%.
By Technique: LC-MS/MS dominated in 2025 with an anticipated 59.6% share in 2026, owing to its high sensitivity and suitability for regulatory compliance testing. GC-MS is projected to grow at 10.3% CAGR.
By Application: The water testing segment led with a 62.6% share in 2025, supported by approximately 9,552 PFAS-contaminated sites across the U.S. alone (Environmental Working Group, 2025). Blood/serum testing is set to grow fastest at 12.2% CAGR.
By End User: Environmental testing laboratories dominated with a 41.7% share in 2026, supported by government-funded testing initiatives. Healthcare & research institutions are projected to grow at 10.8% CAGR.
Regional Outlook
- North America remains the market leader, valued at USD 171.0 million in 2025, driven by EPA regulatory activity, state-level mandates, and growing PFAS remediation projects.
- Europe reached USD 106.0 million in 2025 (10.5% CAGR) due to stringent EU regulations and rising lab investment.
- Asia Pacific secured the third position at USD 78.9 million in 2025, with China contributing USD 25.6 million and India USD 9.9 million.
- Latin America recorded USD 12.1 million in 2025, with growth tied to expanding regulatory frameworks and accredited lab capacity.
Competitive Landscape
Key players include Thermo Fisher Scientific Inc. and Agilent Technologies, Inc. — both leading innovators in PFAS instrumentation. Other prominent players are Merck KGaA, Waters Corporation, PerkinElmer, Shimadzu Corporation, SGS SA, Intertek Group, Babcock Laboratories, and AccuStandard.
Notable developments include Thermo Fisher's October 2025 launch of the Orbitrap Exploris EFOX system for food safety and environmental analysis, and Shimadzu's August 2025 introduction of the LCMS-8065XE platform in international markets.
Outlook
The PFAS testing market is positioned for sustained expansion through 2034. Technological advances in high-resolution mass spectrometry, growing adoption in developing nations, and increasing accreditation of testing services across food, cosmetics, and human biomonitoring sectors will be key growth enablers in the years ahead.
`
Top comments (0)